Developer docs
API playgroundTry for free, no card

Search company profiles

北京天坛普华医院有限公司

Full company profile

uuid0055t5s

Namestring
北京天坛普华医院有限公司
Legal namestring
北京天坛普华医院有限公司
Websiteurl
puhuachina.cn
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Beijing Tiantan Puhua Hospital Co., Ltd. (北京天坛普华医院有限公司) is a Sino-foreign joint venture specialty hospital founded in 1995 in Dongcheng District, Beijing, operating 120 licensed beds across neurosurgery, neurology, interventional neuroradiology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation. The hospital originated as Beijing Tiantan Hospital's VIP/International Department and was formally established as an independent hospital in 2005; it was acquired in 2016 by Bain Capital through its purchase of parent group Asia Pacific Medical Group (APMG). The hospital differentiates itself by aggregating a network of 1,000+ Grade-A hospital specialists — including 150+ attending physicians (50+ neurosurgery specialists) from Beijing Tiantan, Xuanwu, Peking Union Medical College, Tumor, Fuwai, Anzhen, Children's, Peking University First/Third, and Friendship hospitals — practicing on-site under a multi-disciplinary treatment (MDT) model.

The hospital's clinical platform is built around advanced capital equipment, including China's first GE Discovery IGS730 mobile interventional robotic angiography system (RMB 50 million investment), a GE Signa Pioneer 3.0T MRI, 1.5T MRI, CT, Carl Zeiss intraoperative microscopy, Brain Lab neurosurgical navigation, Class 100 laminar flow operating rooms, and a March 2025-launched LITT (MR-guided laser interstitial thermal therapy) system for drug-resistant epilepsy. Outpatient volume exceeds 20,000 visits annually with thousands of surgeries, and the hospital serves patients from 100+ countries. Revenue is generated through specialist outpatient consultations, inpatient and surgical procedures, advanced diagnostic imaging, comprehensive rehabilitation (incorporating Japanese Aizawa Hospital protocols), and premium cross-border/international medical services — with no public price list, quote-based pricing, and direct billing via 36+ commercial insurance partners. Distribution runs through WeChat-based booking, a dedicated appointment hotline (010-67027708), third-party platforms (114, 好大夫, 12580), commercial insurance direct billing, and direct enterprise relationships with foreign embassies and multinational corporations designating the hospital as their medical advisory institution.

Ownership is held through APMG (parent), which was acquired by Bain Capital in 2016; the World Bank and Yingshan Fund also reportedly invested at the operating level. The wholly-owned 二七医保定点神经康复分院 (Erqi Designated Neurorehabilitation Branch) extends the group's rehabilitation footprint. Recent strategic moves have centered on capability-deepening capital equipment (IGS730, LITT), digital patient-acquisition channels (24-hour WeChat consultation), and international partnership expansion (Aizawa Hospital rehabilitation methodology). Leadership includes President/CEO Yang Shichun (杨世春), Vice President/Neurosurgery Director Han Xiaodi (韩小弟), and Neurology Director Yang Ling (杨玲), supported by named elite specialists such as Zhang Junting (chief neurosurgeon, multiple national awards) and Wu Zhen (skull base tumor specialist).

Short descriptiontext

Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture specialty hospital in Beijing operating 120 beds across neurosurgery, neurology, oncology, and rehabilitation, aggregating 1,000+ Grade-A hospital specialists and serving patients from 100+ countries with premium, internationally coordinated care.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurosurgery services, neurology treatment, oncology care, rehabilitation medicine, cross-border healthcare
Industry2 codes
1Neurology & Neurosurgical Specialty Hospitals
CodeHLAFAHADPrimaryYes
2International/Medical Tourism Hospital Systems
CodeHLAFAAANPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • General Medical and Surgical Hospitals622110
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Specialty Hospital Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Medical consultation and outpatient services
TypeSubscription Recurring
Description

Revenue generated from specialist outpatient consultations across neurology, neurosurgery, oncology, orthopedics, obstetrics & gynecology, and other departments. Patients can book appointments via hotline or WeChat.

puhuachina.cn
2Inpatient hospitalization and surgical procedures
TypeOne Time License
Description

Revenue from inpatient beds (120 licensed beds), complex neurosurgical and other high-acuity surgeries, post-operative care, and rehabilitation services. Thousands of surgeries performed annually.

puhuachina.cn
3Commercial insurance direct billing
TypeTransaction Fee
Description

Direct settlement with 36+ commercial insurance companies including Ping An, CPIC, and others listed on the hospital's partnership page. Insurance holders can be directly admitted and billed through their insurance coverage.

puhuachina.cn
4Cross-border / international medical services
TypeProfessional Services
Description

Premium add-on medical services unavailable at public hospitals, including cross-border medical treatment, international patient transfers (e.g., international pediatric referrals), overseas rehabilitation, and foreign diplomatic/corporate client services. The hospital serves patients from 100+ countries.

puhuachina.cn
5Advanced diagnostic imaging and testing services
TypeOne Time License
Description

Revenue from advanced diagnostic equipment including 3.0T MRI, 1.5T MRI, CT, angiography, video EEG, EMG, and other specialized neurological diagnostic procedures.

puhuachina.cn
6Rehabilitation services
TypeSubscription Recurring
Description

Comprehensive rehabilitation services combining physical therapy, occupational therapy, speech therapy, psychological therapy, and Japanese-standard rehabilitation protocols in partnership with Aizawa Hospital, forming a full-cycle rehabilitation system.

puhuachina.cn
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Standard outpatient consultation and treatment
ModelOtherBilling cadencePay-as-you-go
Notes

Appointment-based consultation with specialists from Grade-A hospitals. Service hours 8:30am–5:30pm via hotline 010-67027708 or WeChat official account. No public price list available; individual treatment costs discussed upon consultation.

puhuachina.cn
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1二七医保定点神经康复分院
Description

北京天坛普华医院旗下的神经康复分院,位于二七地区,为医保定点医疗机构。

puhuachina.cn
Core offering1 text field

Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture international hospital in Beijing offering specialized clinical services across neurosurgery, neurology, interventional neuroradiology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation medicine. The hospital aggregates more than 1,000 Grade-A hospital specialists under a multi-disciplinary treatment (MDT) model supported by advanced equipment including the GE Discovery IGS730 mobile interventional robot, GE 3.0T MRI, Brain Lab neurosurgical navigation, and an MR-guided laser ablation (LITT) system. Premium add-on services include cross-border medical care for patients from 100+ countries, commercial insurance direct billing with 36+ partner insurers, and 24-hour online consultations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 20 years of operation, served patients from 100+ countries and regions
+4 more records
Product overview1 text field

北京天坛普华医院 is a China-US joint venture international medical institution established in 1995, offering a comprehensive portfolio of clinical services spanning neurosurgery, neurology, neuroradiology/interventional neurology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation medicine. The hospital operates as a unified medical service platform rather than a modular software product. Clinical services are organized by department (神经外科, 神经内科, 肿瘤科, 妇产科, 骨科, 普外科, 心内科, 神经介入科), supported by a Medical Imaging Center (影像中心) featuring GE 3.0T/1.5T MRI, CT, and the GE Discovery IGS730 mobile robot vascular system, and a Rehabilitation Medical Center (康复医学中心) combining Western rehabilitation with Japanese methodology. The hospital also provides specialty services including LITT (MRI-guided laser ablation) for drug-resistant epilepsy, cross-border/international medical services, 24-hour online consultation via WeChat, and appointment registration through hotline, WeChat, and third-party platforms. The portfolio integrates advanced diagnostic imaging, surgical intervention, rehabilitation, and digital patient services into a coordinated care model.

Product and service1 record
1Neurosurgery (神经外科)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1日本社会医疗法人财团慈泉会相泽医院 (Japan Aizawa Hospital)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

The hospital strengthened cooperation with Aizawa Hospital to introduce authentic rehabilitation concepts to China. The partnership established a comprehensive rehabilitation treatment system covering pre-admission, during admission, and post-discharge, including dietary guidance, activity programs, psychological support, and behavioral rehabilitation for patients.

puhuachina.cn
Strategic tierCoreTypeTechnology or Integration
Description

GE Healthcare partnered with the hospital to deploy China's first Discovery IGS730 mobile robotic angiography system. The hospital became the first domestic training base for the system. CEO Yang Shichun was invited to visit GE's Chengdu R&D base for the high-end hybrid operating room clinical application seminar.

336+ Commercial Insurance Companies
Strategic tierCoreTypeGTM or Marketing Partner
Description

36+ commercial insurance companies including Ping An, CPIC, and others provide direct billing services for insured patients at Beijing Tiantan Puhua Hospital. This enables cashless treatment for insured patients and drives high-value patient referrals to the hospital. The hospital's dedicated insurance coordination team handles GOP (guarantee of payment) processing and claim settlements.

puhuachina.cn
4北京天坛医院 (Beijing Tiantan Hospital)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Original joint venture partner since 1993. Beijing Tiantan Hospital provides its international/special needs department and continues to supply top neurosurgery and neurology specialists who practice at the hospital through multi-point practice arrangements. The hospital originated as Tiantan Hospital's special VIP/International department.

puhuachina.cn
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global specialty hospital leader with strong neurology and neurosurgery franchise, international sites (Abu Dhabi, London), and cross-border patient programs. Represents the global benchmark Puhua aspires to compete with in medical tourism flows.

TypeEmerging player
Description

Premium private specialty hospital chain in Beijing focusing on OB/GYN, pediatrics, and assisted reproduction. Similar premium high-end positioning and Sino-foreign JV heritage; competes for affluent Beijing families seeking private care.

3北京新世纪儿童医院 (New Century International Children's Hospital)
TypeEmerging player
Description

Pediatric-focused private hospital in Beijing with international patient services and insurance direct billing. Comparable in Beijing location and premium positioning; overlaps on pediatric neurosurgery referral cases from the same affluent families.

TypeDirect peer
Description

Premium private hospital group across China with similar high-end international patient positioning, multi-specialty capability, and commercial insurance direct billing. Closely comparable in Beijing footprint, JV heritage, and concierge service model.

TypeDirect peer
Description

Shanghai-based premium private hospital system serving high-net-worth patients and international clients. Comparable in high-end positioning, multi-specialty capability, and Tier-1 city focus; competes for similar cross-border medical tourism flows.

6香港港安医院 (Hong Kong Adventist Hospital)
TypeRegional player
Description

International-standard private hospital in Hong Kong serving mainland Chinese medical tourism patients. Comparable cross-border positioning; regional rather than direct Beijing competitor, but competes for the same outbound Chinese patient pool.

TypeBroad incumbent
Description

Large private healthcare group backed by Taikang Insurance, operating premium hospitals across China. Broader scale and insurance vertical integration; less neurosurgery specialty depth but competes for high-end Tier-1 city patients.

TypeDirect peer
Description

Sino-foreign joint venture hospital in Beijing established in the early 2000s with similar origin to Puhua. Competes in the same high-end private Beijing market with multi-specialty services and cross-border patient focus.

TypeBroad incumbent
Description

Premium academic-affiliated hospital in Beijing with comprehensive specialty services. Public-affiliated but operates with private-style premium service model mirroring Taiwan Changgung model; competes for high-end Beijing patients.

TypeDirect peer
Description

Leading neurosurgery specialty hospital group in China with Beijing, Chongqing, and other locations. Most directly competes for complex neurosurgery patients and operates a similar Grade-A specialist aggregation model. Publicly listed on Shenzhen Stock Exchange (301293.SZ).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

北京天坛普华医院有限公司

Specialty Hospital Servicespuhuachina.cn

Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture specialty hospital in Beijing operating 120 beds across neurosurgery, neurology, oncology, and rehabilitation, aggregating 1,000+ Grade-A hospital specialists and serving patients from 100+ countries with premium, internationally coordinated care.

What 北京天坛普华医院有限公司 does

Beijing Tiantan Puhua Hospital Co., Ltd. (北京天坛普华医院有限公司) is a Sino-foreign joint venture specialty hospital founded in 1995 in Dongcheng District, Beijing, operating 120 licensed beds across neurosurgery, neurology, interventional neuroradiology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation. The hospital originated as Beijing Tiantan Hospital's VIP/International Department and was formally established as an independent hospital in 2005; it was acquired in 2016 by Bain Capital through its purchase of parent group Asia Pacific Medical Group (APMG). The hospital differentiates itself by aggregating a network of 1,000+ Grade-A hospital specialists — including 150+ attending physicians (50+ neurosurgery specialists) from Beijing Tiantan, Xuanwu, Peking Union Medical College, Tumor, Fuwai, Anzhen, Children's, Peking University First/Third, and Friendship hospitals — practicing on-site under a multi-disciplinary treatment (MDT) model.

The hospital's clinical platform is built around advanced capital equipment, including China's first GE Discovery IGS730 mobile interventional robotic angiography system (RMB 50 million investment), a GE Signa Pioneer 3.0T MRI, 1.5T MRI, CT, Carl Zeiss intraoperative microscopy, Brain Lab neurosurgical navigation, Class 100 laminar flow operating rooms, and a March 2025-launched LITT (MR-guided laser interstitial thermal therapy) system for drug-resistant epilepsy. Outpatient volume exceeds 20,000 visits annually with thousands of surgeries, and the hospital serves patients from 100+ countries. Revenue is generated through specialist outpatient consultations, inpatient and surgical procedures, advanced diagnostic imaging, comprehensive rehabilitation (incorporating Japanese Aizawa Hospital protocols), and premium cross-border/international medical services — with no public price list, quote-based pricing, and direct billing via 36+ commercial insurance partners. Distribution runs through WeChat-based booking, a dedicated appointment hotline (010-67027708), third-party platforms (114, 好大夫, 12580), commercial insurance direct billing, and direct enterprise relationships with foreign embassies and multinational corporations designating the hospital as their medical advisory institution.

Ownership is held through APMG (parent), which was acquired by Bain Capital in 2016; the World Bank and Yingshan Fund also reportedly invested at the operating level. The wholly-owned 二七医保定点神经康复分院 (Erqi Designated Neurorehabilitation Branch) extends the group's rehabilitation footprint. Recent strategic moves have centered on capability-deepening capital equipment (IGS730, LITT), digital patient-acquisition channels (24-hour WeChat consultation), and international partnership expansion (Aizawa Hospital rehabilitation methodology). Leadership includes President/CEO Yang Shichun (杨世春), Vice President/Neurosurgery Director Han Xiaodi (韩小弟), and Neurology Director Yang Ling (杨玲), supported by named elite specialists such as Zhang Junting (chief neurosurgeon, multiple national awards) and Wu Zhen (skull base tumor specialist).

北京天坛普华医院有限公司 firmographics

Firmographics
Name
北京天坛普华医院有限公司
Legal name
北京天坛普华医院有限公司
Website
https://puhuachina.cn
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture specialty hospital in Beijing operating 120 beds across neurosurgery, neurology, oncology, and rehabilitation, aggregating 1,000+ Grade-A hospital specialists and serving patients from 100+ countries with premium, internationally coordinated care.
Ownership category
akta.pro rank

北京天坛普华医院有限公司 industry classification

Industry
Product category
Specialty Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)
akta.pro secondary industry
International/Medical Tourism Hospital Systems (HLAFAAAN)

Keywords

  • Neurosurgery services
  • Neurology treatment
  • Oncology care
  • Rehabilitation medicine
  • Cross-border healthcare

Where 北京天坛普华医院有限公司 is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices1 record

Markets served

北京天坛普华医院有限公司 business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Medical consultation and outpatient services: Revenue generated from specialist outpatient consultations across neurology, neurosurgery, oncology, orthopedics, obstetrics & gynecology, and other departments. Patients can book appointments via hotline or WeChat.
  2. Inpatient hospitalization and surgical procedures: Revenue from inpatient beds (120 licensed beds), complex neurosurgical and other high-acuity surgeries, post-operative care, and rehabilitation services. Thousands of surgeries performed annually.
  3. Commercial insurance direct billing: Direct settlement with 36+ commercial insurance companies including Ping An, CPIC, and others listed on the hospital's partnership page. Insurance holders can be directly admitted and billed through their insurance coverage.
  4. Cross-border / international medical services: Premium add-on medical services unavailable at public hospitals, including cross-border medical treatment, international patient transfers (e.g., international pediatric referrals), overseas rehabilitation, and foreign diplomatic/corporate client services. The hospital serves patients from 100+ countries.
  5. Advanced diagnostic imaging and testing services: Revenue from advanced diagnostic equipment including 3.0T MRI, 1.5T MRI, CT, angiography, video EEG, EMG, and other specialized neurological diagnostic procedures.
  6. Rehabilitation services: Comprehensive rehabilitation services combining physical therapy, occupational therapy, speech therapy, psychological therapy, and Japanese-standard rehabilitation protocols in partnership with Aizawa Hospital, forming a full-cycle rehabilitation system.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard outpatient consultation and treatment

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

北京天坛普华医院有限公司 product offering

Product offering

Core offering

Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture international hospital in Beijing offering specialized clinical services across neurosurgery, neurology, interventional neuroradiology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation medicine. The hospital aggregates more than 1,000 Grade-A hospital specialists under a multi-disciplinary treatment (MDT) model supported by advanced equipment including the GE Discovery IGS730 mobile interventional robot, GE 3.0T MRI, Brain Lab neurosurgical navigation, and an MR-guided laser ablation (LITT) system. Premium add-on services include cross-border medical care for patients from 100+ countries, commercial insurance direct billing with 36+ partner insurers, and 24-hour online consultations.

Product overview

北京天坛普华医院 is a China-US joint venture international medical institution established in 1995, offering a comprehensive portfolio of clinical services spanning neurosurgery, neurology, neuroradiology/interventional neurology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation medicine. The hospital operates as a unified medical service platform rather than a modular software product. Clinical services are organized by department (神经外科, 神经内科, 肿瘤科, 妇产科, 骨科, 普外科, 心内科, 神经介入科), supported by a Medical Imaging Center (影像中心) featuring GE 3.0T/1.5T MRI, CT, and the GE Discovery IGS730 mobile robot vascular system, and a Rehabilitation Medical Center (康复医学中心) combining Western rehabilitation with Japanese methodology. The hospital also provides specialty services including LITT (MRI-guided laser ablation) for drug-resistant epilepsy, cross-border/international medical services, 24-hour online consultation via WeChat, and appointment registration through hotline, WeChat, and third-party platforms. The portfolio integrates advanced diagnostic imaging, surgical intervention, rehabilitation, and digital patient services into a coordinated care model.

Differentiator

Problem solved

Functional benefit

Brands

  • 二七医保定点神经康复分院: 北京天坛普华医院旗下的神经康复分院,位于二七地区,为医保定点医疗机构。

Products and services

  • Neurosurgery (神经外科)

Quantifiable outcome

  • Over 20 years of operation, served patients from 100+ countries and regions
  • +4 more outcomes

Companies that use 北京天坛普华医院有限公司

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

北京天坛普华医院有限公司 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

北京天坛普华医院有限公司 partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • 日本社会医疗法人财团慈泉会相泽医院 (Japan Aizawa Hospital)coreStrategic or Co-development Partner · 1 January 2020The hospital strengthened cooperation with Aizawa Hospital to introduce authentic rehabilitation concepts to China. The partnership established a comprehensive rehabilitation treatment system covering pre-admission, during admission, and post-discharge, including dietary guidance, activity programs, psychological support, and behavioral rehabilitation for patients.
  • GE Healthcare (GE医疗)coreTechnology or IntegrationGE Healthcare partnered with the hospital to deploy China's first Discovery IGS730 mobile robotic angiography system. The hospital became the first domestic training base for the system. CEO Yang Shichun was invited to visit GE's Chengdu R&D base for the high-end hybrid operating room clinical application seminar.
  • 36+ Commercial Insurance CompaniescoreGTM or Marketing Partner36+ commercial insurance companies including Ping An, CPIC, and others provide direct billing services for insured patients at Beijing Tiantan Puhua Hospital. This enables cashless treatment for insured patients and drives high-value patient referrals to the hospital. The hospital's dedicated insurance coordination team handles GOP (guarantee of payment) processing and claim settlements.
  • 北京天坛医院 (Beijing Tiantan Hospital)coreStrategic or Co-development PartnerOriginal joint venture partner since 1993. Beijing Tiantan Hospital provides its international/special needs department and continues to supply top neurosurgery and neurology specialists who practice at the hospital through multi-point practice arrangements. The hospital originated as Tiantan Hospital's special VIP/International department.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

北京天坛普华医院有限公司 competitors and assessment

Company assessment

Broad incumbents

  • Cleveland Clinic: Global specialty hospital leader with strong neurology and neurosurgery franchise, international sites (Abu Dhabi, London), and cross-border patient programs. Represents the global benchmark Puhua aspires to compete with in medical tourism flows.
  • 泰康医疗 (Taikang Medical): Large private healthcare group backed by Taikang Insurance, operating premium hospitals across China. Broader scale and insurance vertical integration; less neurosurgery specialty depth but competes for high-end Tier-1 city patients.
  • 清华大学长庚医院 (Tsinghua University Changgung Hospital): Premium academic-affiliated hospital in Beijing with comprehensive specialty services. Public-affiliated but operates with private-style premium service model mirroring Taiwan Changgung model; competes for high-end Beijing patients.

Emerging players

  • 美中宜和医疗 (Amcare Healthcare): Premium private specialty hospital chain in Beijing focusing on OB/GYN, pediatrics, and assisted reproduction. Similar premium high-end positioning and Sino-foreign JV heritage; competes for affluent Beijing families seeking private care.
  • 北京新世纪儿童医院 (New Century International Children's Hospital): Pediatric-focused private hospital in Beijing with international patient services and insurance direct billing. Comparable in Beijing location and premium positioning; overlaps on pediatric neurosurgery referral cases from the same affluent families.

Direct peers

  • 和睦家医疗 (United Family Healthcare): Premium private hospital group across China with similar high-end international patient positioning, multi-specialty capability, and commercial insurance direct billing. Closely comparable in Beijing footprint, JV heritage, and concierge service model.
  • 嘉会医疗 (Jiahui Health): Shanghai-based premium private hospital system serving high-net-worth patients and international clients. Comparable in high-end positioning, multi-specialty capability, and Tier-1 city focus; competes for similar cross-border medical tourism flows.
  • 北京二十一世纪医院 (Beijing 21st Century Hospital): Sino-foreign joint venture hospital in Beijing established in the early 2000s with similar origin to Puhua. Competes in the same high-end private Beijing market with multi-specialty services and cross-border patient focus.
  • 三博脑科医院集团 (Sanbo Brain Hospital Group): Leading neurosurgery specialty hospital group in China with Beijing, Chongqing, and other locations. Most directly competes for complex neurosurgery patients and operates a similar Grade-A specialist aggregation model. Publicly listed on Shenzhen Stock Exchange (301293.SZ).

Regional players

  • 香港港安医院 (Hong Kong Adventist Hospital): International-standard private hospital in Hong Kong serving mainland Chinese medical tourism patients. Comparable cross-border positioning; regional rather than direct Beijing competitor, but competes for the same outbound Chinese patient pool.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

北京天坛普华医院有限公司 social profiles

Digital presence

北京天坛普华医院有限公司 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

北京天坛普华医院有限公司 leadership team

Management profile

Number of profiles

Profiles3 records

北京天坛普华医院有限公司 subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

北京天坛普华医院有限公司 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

北京天坛普华医院有限公司 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 北京天坛普华医院有限公司

What does 北京天坛普华医院有限公司 do?

Beijing Tiantan Puhua Hospital is a Sino-foreign joint venture international hospital in Beijing offering specialized clinical services across neurosurgery, neurology, interventional neuroradiology, oncology, obstetrics & gynecology, orthopedics, general surgery, cardiology, and rehabilitation medicine. The hospital aggregates more than 1,000 Grade-A hospital specialists under a multi-disciplinary treatment (MDT) model supported by advanced equipment including the GE Discovery IGS730 mobile interventional robot, GE 3.0T MRI, Brain Lab neurosurgical navigation, and an MR-guided laser ablation (LITT) system. Premium add-on services include cross-border medical care for patients from 100+ countries, commercial insurance direct billing with 36+ partner insurers, and 24-hour online consultations.

Is 北京天坛普华医院有限公司 a public or private company?

北京天坛普华医院有限公司 is a private company. It is classified as private equity controlled and is currently operating.

When was 北京天坛普华医院有限公司 founded?

北京天坛普华医院有限公司 was founded in 1995. It employs 11 to 50 people.

Where is 北京天坛普华医院有限公司 based?

北京天坛普华医院有限公司 is headquartered in Beijing, China, in the Asia region.

How does 北京天坛普华医院有限公司 make money?

Six revenue lines are on record. Medical consultation and outpatient services are the primary driver. The others are inpatient hospitalization and surgical procedures, commercial insurance direct billing, cross-border / international medical services, advanced diagnostic imaging and testing services and rehabilitation services.

Who are 北京天坛普华医院有限公司's main competitors?

Broad incumbents on record are Cleveland Clinic, 泰康医疗 (Taikang Medical) and 清华大学长庚医院 (Tsinghua University Changgung Hospital). Emerging players are 美中宜和医疗 (Amcare Healthcare) and 北京新世纪儿童医院 (New Century International Children's Hospital). Direct peers are 和睦家医疗 (United Family Healthcare), 嘉会医疗 (Jiahui Health), 北京二十一世纪医院 (Beijing 21st Century Hospital) and 三博脑科医院集团 (Sanbo Brain Hospital Group). 香港港安医院 (Hong Kong Adventist Hospital) is listed as a regional player.

Does 北京天坛普华医院有限公司 have an API?

No public API is recorded for 北京天坛普华医院有限公司.

What industry is 北京天坛普华医院有限公司 in?

北京天坛普华医院有限公司's product category is Specialty Hospital Services. Its primary akta.pro industry code is HLAFAHAD, Neurology & Neurosurgical Specialty Hospitals, with a secondary code of HLAFAAAN, International/Medical Tourism Hospital Systems. Its NAICS code is 6223 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales